BKV LT-ag peptide LLLIWFRPV (HLA-B*0201)

Single peptide synthesized as presented by the MHC class I allele
BKV LT-ag peptide LLLIWFRPV (HLA-B*0201) is a single peptide for stimulation of T cells. The peptide from BK polyomavirus (BKV) large tumor antigen (LT-ag) is synthesized as it is presented by the MHC class I HLA-B*0201 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells. The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.


Form: Lyophilized powder
Peptide Sequence: LLLIWFRPV
Possible Application: T cell stimulation
Purity: > 85%
Sterility: Sterile

Shipping information

Storage: -20 °C
Stability: 12 months after shipping
Shipping: Room temperature

Related Products

CD8 Fab-TACS® Agarose Column Starter Kit, human
Label-free isolation of cytotoxic T cells from whole blood, buffy coat or PBMCs
CD8 Fab-TACS® Magnetic Microbead Starter Kit, human
Label-free isolation cytotoxic T cells from PBMCs
MHC I-Strep HLA-A*0201; BKV LT-antigen (LLLIWFRPV)
MHC class I molecule fused to a Twin-Strep-tag® and refolded with a peptide